Invariant chain protects class II histocompatibility antigens from binding intact polypeptides in the endoplasmic reticulum

EMBO Journal

Volumn 15, Issue 2, 1996, Pages 418-428

  Busch, Robert ^a,c   Cloutier, Isabelle ^b   Sékaly, Rafick Pierre ^b   Hämmerling, Günter J ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Antigen presentation; H 2 A(k); HLA DR; Intracellular transport; MHC

Indexed keywords

DIMER; GLYCOPROTEIN; HLA ANTIGEN CLASS 2; HLA DR1 ANTIGEN; POLYPEPTIDE;

ANTIGEN BINDING; ARTICLE; BINDING SITE; CELL SURFACE; COMPLEX FORMATION; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; POINT MUTATION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; STRUCTURE ACTIVITY RELATION;

EID: 0030052495     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1460-2075.1996.tb00372.x     Document Type: Article

References (64)

1. Altmann, D.M., Heyes, J.M., Ikeda, H., Sadler, A.M., Wilkinson, D., Madrigal, J.A., Bodmer, J.G. and Trowsdale, J (1990) Fine mapping of HLA class II monoclonal antibody specificities using transfected L cells. Immunogenetics, 32, 51-55.
2. Anderson, K.S. and Cresswell, P. (1994) A role for calnexin (IP90) in the assembly of class II MHC molecules. EMBO J., 13, 675-682
3. Anderson, M.S. and Miller, J. (1992) Invariant chain can function as a chaperone protein for class II major histocompatibility complex molecules. Proc. Natl Acad. Sci. USA, 89, 2282-2286.
4. Avva, R.R. and Cresswell, P (1994) In vivo and in vitro formation and dissociation of HLA-DR complexes with invariant chain-derived peptides. Immunity, 1, 763-774.
5. Barnstable, C.J., Bodmer, W.F., Brown, G., Galfré, G., Milstein, C. Williams, A.F. and Ziegler, A. (1978) Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens - new tools for genetic analysis. Cell, 14, 9-20.
6. Bertolino, P., Forquet, F., Pont, S., Koch, N., Gerlier, D. and Rabourdin-Combe, C. (1991) Correlation between invariant chain expression level and capability to present antigen to MHC class II-restricted T cells. Int. Immunol., 3, 435-443.
7. Bijlmakers, M -J.J.E., Benaroch, P. and Ploegh, H.L (1994) Assembly of HLA-DRI molecules translated in vitro. binding of peptide in the endoplasmic reticulum precludes association with invariant chain. EMBO J., 13, 2699-2707.
8. + T cell selection in mice lacking invariant chain. J. Exp. Med., 177, 1699-1712.
9. Bodmer, H , Viville, S., Benoist, C. and Mathis, D. (1994) Diversity of endogenous epitopes bound to MHC class II molecules limited by invariant chain. Science, 263, 1284-1286.
10. Bonnerot, C., Marks, M.S., Cosson, P., Robertson, E.J., Bikoff, E.K., Germain, R.N. and Bonifacino, J.S. (1994) Association with BiP and aggregation of class II MHC molecules synthesized in the absence of invariant chain. EMBO J., 13, 934-944.
11. Bouvier, M. and Wiley, D.C. (1994) Importance of peptide amino and carboxyl termini to the stability of MHC class I molecules Science, 265, 398-402
12. Brown, J.H., Jardetzky, T.S., Gorga, J.C., Stern, L.J., Urban, R G., Strominger, J.L. and Wiley, D.C. (1993) Three dimensional structure of the human class II histocompatibility antigen HLA-DR1 Nature, 364, 33-39.
13. Busch, R., Vturina, I.Y., Drexler, J., Momburg, F. and Hämmerlig, G.J. (1995) Poor loading of major histocompatibility complex class II molecules with endogenously synthesized short peptides in the absence of invariant chain. Eur. J. Immunol., 25, 48-53.
14. Capps, G.G., Robinson, B.E., Lewis, K.D. and Zuñiga, M.C. (1993) In vivo dimeric association of class I MHC heavy chains. Possible relationship to class I MHC heavy chain-β2-microglobulin dissociation. J. Immunol., 151, 159-169.
15. Clements, V.K , Baskar, S., Armstrong, T.D. and Ostrand-Rosenberg, S. (1992) Invariant chain alters the malignant phenotype of MHC class II tumor cells J. Immunol., 149, 2391-2396.
16. Cresswell, P. (1994) Assembly, transport, and function of MHC class II molecules. Annu Rev. Immunol., 12, 259-293
17. Dellabona, P., Peccoud, J., Kappler, J., Marrack, P., Benoist, C. and Mathis, D. (1990) Superantigens interact with MHC class II molecules outside of the antigen binding groove. Cell, 62, 1115-1121.
18. Dodi, A.I., Brett, S., Nordeng, T., Sidhu, S., Batchelor, R.J., Lombardi, G., Bakke, O and Lechler, R.I. (1994) The invariant chain inhibits presentation of endogenous antigens by a human fibroblast cell line. Eur. J. Immunol., 24, 1632-1639.
19. Elliott, E A., Drake, J.R., Amigorena, S., Elsemore, J., Webster, P., Mellman, I. and Flavell, R.A. (1994) The invariant chain is required for intracellular transport and function of major histocompatibility complex class II molecules. J. Exp. Med., 179, 681-694.
20. Flajnik, M F., Canel, C., Kramer, I. and Kasahara, M. (1991) Which came first, MHC class I or class II? Immunogenetics, 33, 295-300.
21. Germain, R.N. and Hendrix, L.R. (1991) MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding. Nature, 353, 134-139.
22. Germain, R.N. and Margulies, D.H (1993) The biochemistry and cell biology of antigen processing and presentation. Annu. Rev Immunol., 11, 403-150
23. Germain, R.N. and Rinker, A.G., Jr (1993) Peptide binding inhibits protein aggregation of invariant chain-free class II dimers and promotes surface expression of occupied molecules. Nature, 363, 725-728.
24. Goding J.W. (1980) Structural studies of murine lymphocyte surface IgD. J. Immunol., 124, 2082-2088.
25. Helenius, A., Marquardt, T. and Braakman, I. (1992) The endoplasmic reticulum as a protein-folding compartment. Trends Cell Biol., 2, 227-231.
26. Hitzel, C., van Endert, P. and Koch, N. (1995) Acquisition of peptides by MHC class II polypeptides in the absence of the invariant chain. J. Immunol., 154, 1048-1056.
27. Koch, N., Koch, S. and Hämmerling, G.J. (1982) Ia invariant chain detected on lymphocyte surfaces by monoclonal antibody Nature, 299, 644-645.
28. Koch, N. Sandrin, M.S., Hämmerling, G.J , Tada, N , Kimura, S. and Hämmerling, U. (1984) Monoclonal antibodies detect polymorphic determinants shared by I-A and I-E antigens. Mol. Immunol., 21, 293-299.
29. Lampson, L.A. and Levy, R. (1980) Two populations of Ia-like molecules, on a human B cell line. J Immunol., 125, 293-299.
30. Landais, D. et al., (1986) The assignment of chain specificities for anti-Ia monoclonal antibodies using L cell transfectants. J. Immunol., 137, 3002-3005.
31. Lanier, L.L., Gutmann, G.A., Lewis, D.E., Griswald, S.T. and Warner, N.L. (1982) Monoclonal antibodies against rat immunoglobulin kappa chain. Hybridoma, 1, 125-131.
32. Lanzavecchia, A., Reid, P.A and Watts, C. (1992) Irreversible association of peptides with class II MHC molecules in living cells. Nature, 357, 249-252.
33. Lemke, H , Hämmerling, G.J. and Hämmerling, U. (1979) Fine specificity analysis with monoclonal antibodies of antigens controlled by the major histocompatibilily complex and by the Qa/TL region in mice. Immunol Rev., 47, 175-206.
34. Lippincott-Schwartz, J., Yuan, L.C., Bonifacino, J.S. and Klausner, R.D. (1989) Rapid redistribution of Golgi proteins into the ER in cells treated with brefeldin A: evidence for membrane cycling from Golgi to ER. Cell, 56, 801-813.
35. Long, E.O., LaVaute, T , Pinet, V and Jaraquemada, D. (1994) Invariant chain prevents the HLA-DR-restricted presentation of a cytosolic peptide. J. Immunol., 153, 1487-1494.
36. Madden, D.R., Gorga, J.C., Strominger, J.L. and Wiley, D.C. (1991) The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation. Nature, 353, 321-325.
37. Madden, D.R., Gorga, J.C., Strominger, J.L. and Wiley, D C. (1992) The three-dimensional structure of HLA-B27 at 2.1 Å resolution suggests a general mechanism for tight peptide binding to MHC. Cell, 70, 1035-1048.
38. Mehringer, J.H., Harris, M.R., Kindle, C.S., McCourt, D.W. and Cullen, S.E. (1991) Characterization of fragments of the murine Ia-associated invariant chain J. Immunol., 146, 920-927.
39. Momburg, F., Neefjes, J.J. and Hammerling, G.J. (1994) Peptide selection by MHC-encoded TAP transporters. Curr. Opin. Immunol., 6, 32-37.
40. Nadimi, F., Moreno, J.A., Momburg, F., Heuser, A., Fuchs, S., Adorini, L. and Hämmerling, G.J. (1991) Antigen presentation of hen egg-white lysozyme but not of ribonuclease A is augmented by the major histocompatibility complex class II-associated invariant chain. Eur. J. Immunol., 21, 1255-1263.
41. Neefjes, J.J. and Ploegh, H.L. (1992a) Inhibition of endosomal proteolytic activity by leupeptin blocks surface expression of MHC class II molecules and their conversion to SDS-resistant αβ heterodimers in endosomes. EMBO J., 11, 411-416.
42. Neefjes, J.J. and Ploegh, H.L. (1992b) Intracellular transport of MHC class II molecules. Immunol. Today, 13, 179-184.
43. Newcomb, J.R. and Cresswell, P. (1993) Characterization of endogenous peptides bound to purified HLA-DR molecules and their absence from invariant chain-associated αβ dimers. J. Immunol., 150, 499-507.
44. Nijenhuis, M., Calafat, J., Kuijpers, K.C., Janssen, H., de Haas, M., Nordeng, T , Bakke, O. and Neefjes, J.J. (1994) Targeting major histocompatibility complex class II molecules to the cell surface by invariant chain allows antigen presentation upon recycling Eur. J. Immunol., 24, 873-883.
45. Peccoud, J., Dellabona, P., Allen, P., Benoist, C. and Mathis, D. (1990) Delineation of antigen contact residues on an MHC class II molecule. EMBO J., 9, 4215-4223
46. Rippmann, F., Taylor, W.R., Rothbard, J.B. and Green, N.M. (1991) A hypothetical model for the peptide binding domain of hsp70 based on the peptide binding domain of HLA. EMBO J., 10, 1053-1059.
47. Roche, P.A. and Cresswell, P. (1990) Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding. Nature, 345, 615-618.
48. Roche, P A., Teletski, C.L , Karp, D.R , Pinet, V., Bakke, O. and Long, E.O. (1992) Stable surface expression of invariant chain prevents peptide presentation by HLA-DR. EMBO J., 11, 2841-2847.
49. Rothbard, J.B and Gefter, M.L. (1991) Interactions between immunogenic peptides and MHC proteins Annu. Rev Immunol , 9, 527-565.
50. Sachs, D.H., Mayer, N and Ozato, K. (1981) Hybridoma antibodies directed toward murine H-2 and Ia antigens. In Hammerling, G.J., Hämmerling, U. and Kearney, J.F. (eds), Monoclonal Antibodies and T Cell Hybridomas Perspectives and Technical Advances. Elsevier Biomedical Press, Amsterdam, pp. 95-101.
51. Sadegh-Nasseri, S. and Germain, R.N. (1992) How MHC class II molecules work: peptide-dependent completion of protein folding. Immunol. Today, 13, 43-46
52. Schaiff, W.T., Hruska, K.A., Jr, McCourt, D.W. Green, M. and Schwartz, B.D. (1992) HLA-DR associates with specific stress proteins and is retained in the endoplasmic reticulum in invariant chain-negative cells. J. Exp. Med., 176, 657-666.
53. Schild, H., Mavaddat, N., Litzenberger, C., Ehrich, E.W., Davis, M.M., Bluestone, J.A., Matis, L., Draper, R.K. and Chien, Y.-H. (1994) The nature of major histocompatibility complex recognition by γδT cells. Cell, 76, 29-37.
54. Schmid, S.L. and Jackson, M.R. (1994) Making class II presentable. Nature, 369, 103-104.
55. Sette, A., Adorini, L., Colon, S M., Buus, S. and Grey, H M. (1989) Capacity of intact proteins to bind to MHC class II molecules. J. Immunol., 143, 1265-1267.
56. Shastri, N., Malissen, B. and Hood, L. (1985) Ia-transfected L-cell fibroblasts present a lysozyme peptide but not the native protein to lysozyme-specific T cells. Proc. Natl Acad Sci. USA, 82, 5885-5889.
57. Simonsen, A., Momburg, F., Drexler, J., Hammerling, G.J. and Bakke, O (1993) Intracellular distribution of the MHC class II molecules and the associated invariant chain (Ii) in different cell lines. Int. Immunol., 5, 903-917.
58. Stockinger, B., Pessara, U , Lin, R.H., Habicht, J., Grez, M. and Koch, N. (1989) A role of Ia-associated invariant chains in antigen processing and presentation. Cell, 56, 683-689.
59. Teyton, L., O'Sullivan, D., Dickson, P.W., Lotteau, V., Sette, A., Fink, P. and Peterson, P.A. (1990) Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways. Nature, 348, 39-44.
60. Thibodeau, J., Cloutier, I., Lavoie, P.M., Labrecque, N., Mourad, W., Jardetzky, T. and Sekaly, R -P. (1994) Subsets of HLA-DR1 molecules defined by SEB and TSST-1 binding. Science, 266, 1874-1878.
61. Viville, S., Neefjes J.J., Lotteau, V., Dierich, A., Lemeur, M , Ploegh, H.L., Benoist, C. and Mathis, D. (1993) Mice lacking the MHC class II-associated invariant chain Cell, 72, 635-648.
62. Watanabe, M., Suzuki, T., Taniguchi, M. and Shinohara, N. (1983) Monoclonal anti-Ia murine alloantibodies cross-reactive with the Ia-homologues of other mammalian species including humans. Transplantation, 36, 712-718.
63. Wenstein, D.A., Boniface, J.J., Reay, P.A., Schild, H. and Davis, M.M. (1991) Expression of a class II major histocompatibility complex (MHC) heterodimer in a lipid-linked form with enhanced peptide/ soluble MHC complex formation at low pH J. Exp. Med., 174, 219-228.
64. Winslow, G.M., Scherer, M.T , Kappler, J.W. and Marrack, P. (1992) Detection and biochemical characterization of the mouse mammary tumor virus 7 superantigen (Mis-1a). Cell, 71, 719-730.